# Anthropic Trust appointed Vas Narasimhan, CEO of Novartis, to Anthropic’s board of directors on April 14, 2026.

*biotech · news · 2026-04-16 · Crypto News*

## Key points

- Vas Narasimhan is the first pharma executive appointed to Anthropic’s board of directors.
- Trust-appointed directors now hold a majority on Anthropic's board for the first time.
- The Long-Term Benefit Trust can direct Anthropic’s board to prioritize responsible AI development.
- Anthropic's Claude for Healthcare initiative has launched partnerships with Eli Lilly, Novo Nordisk, and Genmab.
- Anthropic’s annualized revenue now exceeds $30 billion, with an IPO potentially valuing it at $380 billion.

**Companies:** Novartis, Anthropic
**Countries:** United States, Switzerland

[Read the full story on Crypto News](https://crypto.news/anthropic-trust-adds-novartis-ceo-to-board/)

---

Canonical: https://newsio.io/n/df1430cc-79c9-4e99-b375-c4a918a4b4f0/anthropic-trust-appointed-vas-narasimhan-ceo-of-novartis-to-anthropics-board-of
Summarized by Newsio from Crypto News. https://newsio.io/how-it-works